共 153 条
[1]
Ungaro R(2017)Ulcerative colitis Lancet 389 1756-1770
[2]
Mehandru S(2020)A qualitative research for defining meaningful attributes for the treatment of inflammatory bowel disease from the patient perspective Patient 13 317-325
[3]
Allen PB(2019)ACG clinical guideline: ulcerative colitis in adults Am J Gastroenterol 114 384-413
[4]
Peyrin-Biroulet L(2019)A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis J Patient Rep Outcomes 3 66-i29
[5]
Colombel JF(2022)OP26 efficacy and safety of mirikizumab as induction therapy in patients with moderately to severely active ulcerative colitis: results from the phase 3 LUCENT-1 study J Crohns Colitis 16 i028-1629
[6]
Louis E(1987)Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study N Engl J Med 317 1625-810
[7]
Ramos-Goni JM(1989)A new measure of health status for clinical trials in inflammatory bowel disease Gastroenterology 96 804-S27
[8]
Cuervo J(1999)Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease J Pediatr Gastroenterol Nutr 28 S23-850
[9]
Kopylov U(2022)Defining changes in physical limitation from the patient perspective: insights from the VITALITY-HFpEF randomized trial Eur J Heart Fail 24 843-661
[10]
Barreiro-de Acosta M(2022)Minimally clinically important difference in health status scores in patients with HFrEF vs. HFpEF JACC Heart Fail 10 651-586